Cost-effectiveness of ABI Screening and Rivaroxaban in CHD

被引：0
|
作者：
Graewert, Stephanie
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2022年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
    Itoga, Nathan K.
    Minami, Hataka R.
    Chelvakumar, Meenadachi
    Pearson, Keon
    Mell, Matthew M.
    Bendavid, Eran
    Owens, Douglas K.
    VASCULAR MEDICINE, 2018, 23 (02) : 97 - 106
  • [2] COST-EFFECTIVENESS OF SCREENING
    POLE, JD
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1971, 64 (12): : 1256 - &
  • [3] The CHD challenge: Comparing four cost-effectiveness models
    Turner, David
    Raftery, James
    Cooper, Keith
    Fairbank, Eleanor
    Palmer, Stephen
    Ward, Sue
    Ara, Roberta
    VALUE IN HEALTH, 2011, 14 (01) : 53 - 60
  • [4] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VS OTHER ANTICOAGULANTS
    Figallo, M.
    Manrique, S.
    Colunge, N.
    Castaneda Aliaga, D.
    Chavez, M.
    Marrugo, R.
    Lopez, C.
    VALUE IN HEALTH, 2022, 25 (07) : S418 - S418
  • [5] COST-EFFECTIVENESS OF RIVAROXABAN FOR THE TREATMENT OF PULMONARY EMBOLISM IN CANADA
    Levac, B.
    Marrie, J.
    Chin, W.
    Hassan, F.
    Bamber, L.
    McLeod, E. J.
    VALUE IN HEALTH, 2014, 17 (03) : A117 - A118
  • [6] The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial
    Lamy, Andre
    Eikelboom, John
    Tong, Wesley
    Yuan, Fei
    Bangdiwala, Shrikant, I
    Bosch, Jackie
    Connolly, Stuart
    Lonn, Eva
    Dagenais, Gilles R.
    Branch, Kelley R. H.
    Wang, Wei-Jhih
    Bhatt, Deepak L.
    Probstfield, Jeff
    Ertl, Georg
    Stoerk, Stefan
    Steg, P. Gabriel
    Aboyans, Victor
    Durand-Zaleski, Isabelle
    Ryden, Lars
    Yusuf, Salim
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (05) : 502 - 510
  • [7] Cost-effectiveness of screening for HIV
    Thrasher, AD
    Ford, CL
    Nearing, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20): : 2137 - 2137
  • [8] COST-EFFECTIVENESS OF LEAD SCREENING
    BERWICK, DM
    KOMAROFF, AL
    SHERMAN, H
    CLINICAL RESEARCH, 1980, 28 (02): : A291 - A291
  • [9] The cost-effectiveness of cervical screening
    Smith, WJ
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1999, 11 (01) : 83 - 85
  • [10] COST-EFFECTIVENESS OF SCREENING FOR HEMOCHROMATOSIS
    GUZMAN, G
    PHATAK, PD
    WOLL, J
    PHELPS, CE
    CLINICAL RESEARCH, 1991, 39 (02): : A348 - A348
12345